Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2022-05-31
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is Bioimpedance Analysis Accurate in Transgender Males?
NCT05728853
Power-speed-endurance Profile (Cycling/Rowing) : Optimize Performance of the French Athletes at the Paris Olympics 2024
NCT05314543
Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome.
NCT06780514
Acute Responses to a Potentiation Warm-up Protocol in Female Football Players.
NCT06555185
Hematological Factors and Iron Status in Aerobic Versus Anaerobic Training in Athletic Females
NCT05707455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transgender women
Well-trained transgender women.
Aerobic exercise test.
Aerobic exercise test at a treadmill.
Cisgender Women
Well-trained cisgender women.
Aerobic exercise test.
Aerobic exercise test at a treadmill.
Cisgender Men
Well-trained cisgender men.
Aerobic exercise test.
Aerobic exercise test at a treadmill.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic exercise test.
Aerobic exercise test at a treadmill.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gonadectomized and non-gonadectomized
* Initiation of androgen blockade and/or estrogen use after 12 years of age.
* Age range 18 to 50 years old.
* BMI: 18.0 to 34.9 kg/m2.
* Well-trained individuals (IPAQ very active)
Exclusion Criteria
* Chronic illnesses and/or chronic medication use.
* Musculoskeletal limitations.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Brasileiro de Controle do Cancer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leonardo Alvares
Medical Technical Director
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
52428321.2.0000.0062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.